copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Repligen | Inspiring advances in bioprocessing Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of its CTech™ SoloVPE ® PLUS System, the most advanced UV-based Variable Pathlength Technology system now available to biopharmaceutical manufacturers
About Repligen Repligen is headquartered in Boston, Massachusetts with major manufacturing sites in Massachusetts, California, and New Jersey in the United States and in Sweden, France, The Netherlands, Germany and Estonia
Products - Repligen Whether you are in fed-batch, hybrid continuous or full continuous mode, or working with therapeutic proteins, gene therapy or vaccines, you can use leading edge solutions from Repligen to streamline your processes and cut your manufacturing costs
Careers - Repligen Working at Repligen means being part of a team that is excited to find new and creative ways to overcome challenges in bioprocessing — and to help our customers make a difference in the world
Repligen Corporation - Investor Relations Investor Relations About Repligen We are a US-based, global developer and manufacturer of highly innovative bioprocessing tools and technologies We provide advanced systems and solutions that enable efficiencies and help set new standards for the way biological drugs are manufactured
News Room - Repligen Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing
Repligen Corporation - Press Releases Repligen Corporation to Present at Upcoming November Conferences Download Repligen Corporation to Present at Upcoming November Conferences in PDF format" (opens in new window)
Repligen Corporation - Financials - Quarterly Results Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs